Russell Investments Group Ltd. Acquires 24,095 Shares of Cencora, Inc. $COR

Russell Investments Group Ltd. increased its holdings in shares of Cencora, Inc. (NYSE:COR) by 11.8% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 228,577 shares of the company’s stock after acquiring an additional 24,095 shares during the quarter. Russell Investments Group Ltd.’s holdings in Cencora were worth $71,374,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. IAG Wealth Partners LLC bought a new position in shares of Cencora during the third quarter valued at $30,000. Vermillion & White Wealth Management Group LLC lifted its holdings in shares of Cencora by 69.4% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after purchasing an additional 43 shares during the period. Cloud Capital Management LLC bought a new stake in shares of Cencora in the third quarter worth $31,000. Caitlin John LLC bought a new stake in shares of Cencora in the third quarter worth $31,000. Finally, Westside Investment Management Inc. increased its holdings in Cencora by 200.0% in the third quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after purchasing an additional 70 shares during the period. 97.52% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. Weiss Ratings raised Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research report on Thursday, February 5th. Wells Fargo & Company increased their price target on Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Jefferies Financial Group upgraded Cencora from an “underperform” rating to a “buy” rating in a research report on Thursday, January 22nd. Wall Street Zen lowered Cencora from a “buy” rating to a “hold” rating in a research note on Friday, November 28th. Finally, Robert W. Baird set a $415.00 target price on Cencora in a report on Tuesday, January 13th. Eleven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $399.00.

Insiders Place Their Bets

In other Cencora news, EVP Silvana Battaglia sold 1,677 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $345.00, for a total value of $578,565.00. Following the transaction, the executive vice president directly owned 18,796 shares of the company’s stock, valued at approximately $6,484,620. The trade was a 8.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Elizabeth S. Campbell sold 3,351 shares of the stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $342.10, for a total value of $1,146,377.10. Following the transaction, the executive vice president owned 23,891 shares in the company, valued at $8,173,111.10. The trade was a 12.30% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 15,220 shares of company stock worth $5,282,867. 0.38% of the stock is owned by corporate insiders.

Cencora Stock Performance

Shares of COR opened at $351.97 on Wednesday. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. The stock has a market capitalization of $68.47 billion, a P/E ratio of 42.30, a price-to-earnings-growth ratio of 1.69 and a beta of 0.68. The firm’s fifty day simple moving average is $354.84 and its two-hundred day simple moving average is $337.51. Cencora, Inc. has a 12 month low of $251.94 and a 12 month high of $377.54.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. The firm had revenue of $85.93 billion during the quarter, compared to the consensus estimate of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The business’s revenue was up 5.5% compared to the same quarter last year. During the same period last year, the business posted $3.73 EPS. As a group, analysts predict that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $2.40 annualized dividend and a yield of 0.7%. Cencora’s dividend payout ratio (DPR) is currently 28.85%.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.